CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...

The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

RWJBarnabas Health research were awarded a $2.4 million grant to develop technology to better manage patients presenting with heart attacks.

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

Brain Pathway Discovery Sheds Light on Higher Depression Rates in Teenage GirlsDepression is a mental health condition that ...

MRI-derived myocardial extracellular volume fraction (ECV) is elevated in the presence of fibrosis, amyloid deposition, inflammation and edema. In patients with cardiac amyloidosis and prolonged T2 ...

and the lungs for crackles, which may indicate heart failure. Electrophysiological changes in myocardial function commonly occur in patients with heart failure secondary to amyloidosis.

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

product use–associated lung injury (EVALI). Among the 1139 patients with EVALI discharged on or before October 31, 2019, 31 (2.7%) were rehospitalized a median of 4 days after discharge and with ...